Cleared Traditional

K990390 - HEPARIN IV FLUSH SYRINGE, 10 U/ML \

K990390 is an FDA 510(k) clearance for HEPARIN IV FLUSH SYRINGE, manufactured by Rocap Div. of Sabratek Corp.. The device is a Class 2 General Hospital device with product code FOZ cleared through the Traditional 510(k) pathway after a 304-day FDA review.

K990390 · Rocap Div. of Sabratek Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1999
Decision
304d
Days
Class 2
Risk

K990390 is an FDA 510(k) clearance for the HEPARIN IV FLUSH SYRINGE, 10 U/ML \. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Rocap Div. of Sabratek Corp. (Orlando, US). The FDA issued a Cleared decision on December 10, 1999 after a review of 304 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Rocap Div. of Sabratek Corp. devices

FDA 510(k) Submission Details - K990390

510(k) Number K990390 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 09, 1999
Decision Date December 10, 1999
Days to Decision 304 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
175d slower than avg
Panel avg: 129d · This submission: 304d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FOZ Device Classification - Class 2, Special Controls

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 352
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K990390.
BD PREEFILE NORMAL SALINE FLUSH SYRINGE FLUSH SYRINGE
K982558 · Bd/Preefil · Mar 2000
ARROWG +ARD BLUE PLUS ANTIMICROBIAL MULTI-LUMEN CENTRAL VENOUS CATHETER
K993691 · Arrow Intl., Inc. · Mar 2000
ROCAP HEPARIN IV FLUSH SYRINGE, 100U/ML
K990308 · Rocap Div. of Sabratek Corp. · Dec 1999
0.9% SODIUM CHLORIDE FLUSH SYRINGE
K984590 · Baxter Healthcare Corp · Oct 1999
URETHANE PICC LINE MODEL UPICS-
K992198 · Cook, Inc. · Aug 1999
MODIFICATION OF JELCO*,JELCO*-W AND JELCO* PLUS I.V. CATHETERS, CATHLON* I.V. CATHETERS, OPTIVA* I.V. CATHETERS, PROTECT
K990236 · Johnson & Johnson Medical, Div. of Ethicon, Inc. · Aug 1999